Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 13, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Cap	369	256	220	235	1,078	1,150
Market Cap Growth	119.24%	16.59%	-6.66%	-78.19%	-6.20%	25.09%
Enterprise Value	319.82	121.9	25.33	-113.44	851.57	906.84
Last Close Price	12.70	11.97	10.36	11.17	51.87	56.81
PE Ratio	-	-3.12	-1.89	-1.75	-8.78	-14.49
PS Ratio	5.50	3.92	3.25	2.97	12.52	11.84
PB Ratio	2.91	3.96	1.70	1.09	3.36	2.88
P/TBV Ratio	2.33	3.95	1.70	1.08	3.33	2.87
P/FCF Ratio	-	-7.96	-2.27	-2.10	-12.41	-16.25
P/OCF Ratio	-	-13.28	-2.79	-2.28	-12.72	-16.43
EV/Sales Ratio	4.77	1.87	0.37	-1.43	9.88	9.34
EV/EBITDA Ratio	-	-1.51	-0.21	0.84	-7.05	-8.54
EV/EBIT Ratio	-	-1.43	-0.21	0.83	-6.88	-8.28
EV/FCF Ratio	-	-3.79	-0.26	1.01	-9.80	-12.82
Debt / Equity Ratio	0.42	0.85	0.42	0.10	0.07	0.00
Debt / EBITDA Ratio	-0.84	-0.72	-0.46	-0.20	-0.21	-0.05
Debt / FCF Ratio	-3.09	-1.80	-0.57	-0.24	-0.29	-0.07
Net Debt / Equity Ratio	-1.02	-2.02	-1.50	-1.58	-0.70	-0.60
Net Debt / EBITDA Ratio	1.89	1.62	1.62	2.55	1.85	2.25
Net Debt / FCF Ratio	6.98	4.07	1.99	3.06	2.58	3.37
Asset Turnover	0.20	0.20	0.16	0.19	0.21	0.21
Quick Ratio	4.34	4.03	4.43	6.03	9.04	7.40
Current Ratio	4.44	4.21	5.20	6.73	10.45	8.82
Return on Equity (ROE)	-60.01%	-84.63%	-67.17%	-49.74%	-33.79%	-18.48%
Return on Assets (ROA)	-21.19%	-25.47%	-28.60%	-33.46%	-30.31%	-17.40%
Return on Invested Capital (ROIC)	-57.27%	-91.08%	-135.89%	-165.70%	-94.18%	-66.38%
Return on Capital Employed (ROCE)	-25.00%	-30.99%	-33.89%	-36.83%	-33.10%	-25.35%
Earnings Yield	-19.41%	-32.08%	-52.90%	-57.12%	-11.39%	-6.90%
FCF Yield	-5.01%	-12.57%	-44.05%	-47.70%	-8.06%	-6.15%
Buyback Yield / Dilution	-15.29%	0.05%	0.07%	0.66%	-1.86%	-0.27%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q